Literature DB >> 17762890

Differentiation plasticity regulated by TGF-beta family proteins in development and disease.

Rik Derynck1, Rosemary J Akhurst.   

Abstract

During development, stem and progenitor cells gradually commit to differentiation pathways. Cell fate decisions are regulated by differentiation factors, which activate transcription programmes that specify lineage and differentiation status. Among these factors, the transforming growth factor (TGF)-beta family is important in both lineage selection and progression of differentiation of most, if not all, cell and tissue types. There is now increasing evidence that TGF-beta family proteins have the ability to redirect the differentiation of cells that either have fully differentiated or have engaged in differentiation along a particular lineage, and can thereby elicit 'transdifferentiation'. This capacity for cellular plasticity is critical for normal embryonic development, but when recapitulated in the adult it can give rise to, or contribute to, a variety of diseases. This is illustrated by the ability of TGF-beta family members to redirect epithelial cells into mesenchymal differentiation and to cause switching of mesenchymal cells from one lineage to another. Hence, various pathologies in adults may be considered diseases of abnormal development and differentiation.

Mesh:

Substances:

Year:  2007        PMID: 17762890     DOI: 10.1038/ncb434

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  165 in total

1.  Fibrodysplasia ossificans progressiva: a human genetic disorder of extraskeletal bone formation, or--how does one tissue become another?

Authors:  Eileen M Shore
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012 Jan-Feb       Impact factor: 5.814

Review 2.  Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Authors:  Thomas Doetschman; Joey V Barnett; Raymond B Runyan; Todd D Camenisch; Ronald L Heimark; Henk L Granzier; Simon J Conway; Mohamad Azhar
Journal:  Cell Tissue Res       Date:  2011-09-28       Impact factor: 5.249

3.  Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin.

Authors:  Parag P Shah; Sham S Kakar
Journal:  Cancer Lett       Date:  2011-07-13       Impact factor: 8.679

4.  Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761.

Authors:  Erin C Connolly; Elise F Saunier; David Quigley; Minh Thu Luu; Angela De Sapio; Byron Hann; Jonathan M Yingling; Rosemary J Akhurst
Journal:  Cancer Res       Date:  2011-01-31       Impact factor: 12.701

5.  EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling.

Authors:  Sang-A Park; Min-Jin Kim; So-Yeon Park; Jung-Shin Kim; Seon-Joo Lee; Hyun Ae Woo; Dae-Kee Kim; Jeong-Seok Nam; Yhun Yhong Sheen
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

Review 6.  Targeting the transforming growth factor-beta signaling pathway in human cancer.

Authors:  Nagathihalli S Nagaraj; Pran K Datta
Journal:  Expert Opin Investig Drugs       Date:  2010-01       Impact factor: 6.206

Review 7.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

8.  Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells.

Authors:  Meng-Lei Zhu; Natasha Kyprianou
Journal:  FASEB J       Date:  2009-11-09       Impact factor: 5.191

9.  The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim-Chester disease.

Authors:  Greta Pacini; Giulio Cavalli; Alessandro Tomelleri; Giacomo De Luca; Guido Pacini; Marina Ferrarini; Claudio Doglioni; Lorenzo Dagna
Journal:  Oncoimmunology       Date:  2018-03-15       Impact factor: 8.110

10.  Plasticity underlies tumor progression: role of Nodal signaling.

Authors:  Thomas M Bodenstine; Grace S Chandler; Richard E B Seftor; Elisabeth A Seftor; Mary J C Hendrix
Journal:  Cancer Metastasis Rev       Date:  2016-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.